Introduction
============

Respiratory tract infection is a major contributor to morbidity and mortality among children and adults worldwide ([@ref-6]; [@ref-14]). Most recognized is the seasonal influenza virus infection, which is responsible for about 290,000 to 650,000 deaths each year ([@ref-45]). Epidemiological studies have shown that infants, young children, and the elderly are especially at risk of infection by both subtypes of RSV (designated A and B) ([@ref-17]). Even hMPV is now recognized as a frequent cause of acute respiratory tract infections in children predominantly ≤5 years of age, elderly adults, and immunocompromised patients ([@ref-22]; [@ref-44]). Each of the two genetically and antigenically distinct groups of hMPV (A and B) can be further divided into genetic subgroups 1 and 2 ([@ref-5]).

Multiple groups of different respiratory viruses frequently co-circulate with a variable pattern of predominance in Thailand. Data on the prevalence of infection caused by these viruses are often incomplete and limited due to their similar clinical presentation and seasonality overlap ([@ref-38]; [@ref-20]). The systematic use of molecular diagnostics such as the real-time reverse transcription-polymerase chain reaction (RT-PCR) assay has been important in improving accurate diagnosis of viral respiratory infections and has proven extremely useful for disease surveillance ([@ref-25]).

Here, we aimed to assess the disease burden caused by RSV, hMPV, and influenza virus in a large patient population of all ages who presented influenza-like illness (ILI) and sought medical care at a hospital in Bangkok within the past two years.

Materials and Methods
=====================

Study design and specimens
--------------------------

We retrospectively tested 8,842 stored respiratory samples obtained from both in-patient and out-patient individuals of all ages with ILI who sought medical care at Bangpakok 9 International Hospital in Bangkok and collected consecutively between January 2016 and December 2017. ILI was defined as fever (\>38 °C) and accompanying respiratory symptoms such as cough, sore throat, or pharyngitis. This study analyzed de-identified convenient samples and extended an earlier investigation of an ongoing influenza virus prevalence in Thailand ([@ref-35]). Available patient information included gender and age, but not extensive clinical information nor disease severity. The Institutional Review Board of the Faculty of Medicine of Chulalongkorn University approved this study (IRB number 609/59).

Real-time RT-PCR
----------------

RNA was extracted from 200 µL of specimens using the Viral Nucleic Acid Extraction Kit (RBC Bioscience, Taiwan, R.O.C.) according to the manufacturer's instructions. RSV and hMPV detections were performed using an in-house TaqMan-based multiplex one-step real-time RT-PCR. The primers and probes targeted the M gene of RSV and the F gene of hMPV ([Table 1](#table-1){ref-type="table"}). The RSV probe was labeled with 6-carboxy-fluorescein (FAM) at the 5′ end and Black Hole Quencher-1 (BHQ-1) at the 3′ end. The hMPV probe was labeled with 6-carboxy-fluorescein (HEX) at the 5′ end and Black Hole Quencher-1 (BHQ-1) at the 3′ end. The reaction mixture contained 2 µL RNA, 10 µmol of each of the primers and probes, and SensiFAST Probe No-ROX One-Step reagent (Bioline, London, UK). Cycling parameters included 1 cycle for 20 min at 42 °C, initial denaturation for 3 min at 95 °C, 50 cycles for 10 s at 95 °C and 20 s at 60 °C. This assay has a limit of detection of 100 genome copies per reaction for both viruses. No cross-detections were observed between the two viruses and other respiratory viruses including influenza A and B viruses, adenovirus, enterovirus, rhinovirus, and coronavirus. Real-time RT-PCR assay of influenza A and B viruses was previously described ([@ref-36]). Parallel detection of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene served as an internal control. Fluorescence signals cycle threshold (Ct) was based on optimization and values ≤38 were considered positive.
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###### Primers and probes used to detect RSV, hMPV, and influenza virus.
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                                             Virus              Primer/Probe   Sequence 5′--3′                        Target   Position    
  ------------------------------------------ ------------------ -------------- -------------------------------------- -------- ----------- -----
  Assay 1                                    RSV A and B        RSV_F3251      GGCAAATATGGAAACATACGTGAA               M        3251-3274   (+)
                                                                RSV_R3334      TCTTTTTCTAGGACATTGTAYTGAACAG           M        3334-3361   (-)
                                                                RSV_P3303      FAM-CTGTGTATGTGGAGCCTTCGTGAAGCT-BHQ1   M        3303-3329   (+)
                                             hMPV A and B       hMPV_F3604     CAARTGYGACATTGCTGAYCTRAA               F        3604-3628   (+)
                                                                hMPV_R3683     ACTGCCGCACAACATTTAGRAA                 F        3683-3662   (-)
                                                                HMPV_P3630     JOE-TGGCYGTYAGCTTCAGTCARTTC-BHQ1       F        3630-3643   (+)
  Assay 2[^a^](#table-1fn1){ref-type="fn"}   Influenza A        FluA-M-F151    CATGGARTGGCTAAAGACAAGACC               M        151-175     (+)
                                                                FluA-M-R276    AGGGCATTTTGGACAAAKCGTCTA               M        276-252     (-)
                                                                FluA-M-P218    FAM-ACGCTCACCGTGCCCAGT-BHQ1            M        218-235     (+)
                                             Influenza B        FluB-MF439     CTCTGTGCTTTRTGCGARAAAC                 M        439-460     (+)
                                                                FluB-MR        CCTTCYCCATTCTTTTGACTTGC                M        671-649     (-)
                                                                FluB-P135      Cy5-TCAGCAATGAACACAGCAA-BHQ3           M        541-559     (+)
                                             Influenza A/H1N1   H1_F           ACTACTGGACTCTGCTKGAA                   H1       750-769     (+)
                                                                H1_R           AAGCCTCTACTCAGTGCGAA                   H1       846-827     (-)
                                                                H1_P           FAM-TTGAGGCAAATGGAAATCTAATAGC-TAMRA    H1       789-813     (+)
                                             Influenza A/H3N2   H3_F           TGCTACTGAGCTGGTTCAGAGT                 H3       139-160     (+)
                                                                H3_R           AGGGTAACAGTTGCTGTRGGC                  H3       322-302     (-)
                                                                H3_P           HEX-AGATGCTCTATTGGGAGACC-BHQ1          H3       226-245     (+)
                                             GAPDH              GAPDH-F85      GTGAAGGTCGGAGTCAACGG                   GAPDH    85-104      (+)
                                                                GAPDH-R191     TCAATGAAGGGGTCATTGATGG                 GAPDH    191-169     (-)
                                                                GAPDH-P121     HEX-CGCCTGGTCACCAGGGCTGC-BHQ1          GAPDH    121-140     (+)

**Notes.**

Previously described in [@ref-36].

(+) and (-) denote sense and anti-sense strand, respectively.

Conventional RT-PCR
-------------------

Samples tested positive for RSV and/or hMPV were genotyped. Complementary DNA was synthesized using the ImProm-II Reverse Transcription System (Promega, Madison, WI, USA) according to the manufacturer's instructions. RNA and random hexamers were incubated at 70 °C for 5 min, followed by extension for 2 h at 42 °C and inactivation at 70  °C for 15 min. Amplification of the partial RSV glycoprotein (G) gene inclusive of the second hypervariable region (HVR2) and the F gene was performed using semi-nested RT-PCR as previously described ([@ref-3]). Cycling parameters were initial denaturation at 94 ° C for 3 min, 40 cycles of denaturation at 94 °C for 20 s, annealing at 55 °C for 20 s, elongation at 72 °C for 90 s, and a final extension at 72  °C for 10 min. Identical amplification parameters were carried out in the second-round PCR for 30 cycles. Partial F-gene of hMPV was subjected to nested-PCR as previously described ([@ref-10]). The PCR conditions were initial denaturation at 95  °C for 3 min, 35 cycles of 95 °C for 1 min, 55 °C for 1 min, 72 °C for 1 min, and a final extension at 72 °C for 3 min. The PCR products for RSV-A (840 bp), RSV-B (720 bp), and hMPV (750 bp) were visualized using 2% agarose gel electrophoresis and purified using the GeneAll Expin gel extraction kit (GeneAll Biotechnology, Seoul, South Korea) according to the manufacturer's instructions. Purified PCR products were subjected to Sanger sequencing.

Sequence and phylogenetic analyses of RSV and hMPV genotypes
------------------------------------------------------------

Nucleotide sequences of RSV and hMPV strains were aligned using ClustalW implemented in BioEdit (version 7.0.9) by comparison to the sequences previously assigned to specific genotypes ([Table S1](#supp-1){ref-type="supplementary-material"} and [Table S2](#supp-2){ref-type="supplementary-material"}). Phylogenetic trees were constructed using the maximum likelihood method implemented in the MEGA6 ([@ref-37]). The reliability of the tree based on the Tamura--Nei model was estimated using 1,000 bootstrap pseudo-replications. Sequences were considered the same genotype if they clustered together with bootstrap values of 70--100% ([@ref-41]).

Nucleotide sequences were submitted to the GenBank database under the accession numbers [MH447703](http://www.ncbi.nlm.nih.gov/nuccore/MH447703)--[MH447725](http://www.ncbi.nlm.nih.gov/nuccore/MH447725) (RSV-A), [MH447726](http://www.ncbi.nlm.nih.gov/nuccore/MH447726)--[MH447818](http://www.ncbi.nlm.nih.gov/nuccore/MH447818) (RSV-B), and [MH447819](http://www.ncbi.nlm.nih.gov/nuccore/MH447819)--[MH447950](http://www.ncbi.nlm.nih.gov/nuccore/MH447950) (hMPV).

Statistical analysis
--------------------

The association between virus prevalence and the patient age at infection was assessed using univariate analyses (SPSS software version 22.0). *P*-values were calculated using the Chi-squared test or Fisher's exact test, where cell counts below 5 were used. A *p*-value of \<0.05 was considered statistically significant.

Results
=======

The overall prevalence of RSV, hMPV, and influenza virus
--------------------------------------------------------

We retrospectively tested 8,842 consecutive respiratory samples (48.5% males, age range 0--106 years). Of these, 30.5% (2,699/8,842) were positive for one or more viruses. Influenza virus was most commonly identified (17.3%, 1,528/8,842), followed by RSV (11.4%, 1,011/8,842) and hMPV (3.6%, 318/8,842) ([Table 2](#table-2){ref-type="table"}). Influenza virus and RSV were more prevalent in 2016 than in 2017. To facilitate analysis, samples were categorized into seven groups in order to examine the distribution of viral infection relative to age ([Table 3](#table-3){ref-type="table"} and [Table S3](#supp-3){ref-type="supplementary-material"}). Regardless of gender, the burden of RSV was greatest among children 5 years of age and younger (21.2% and 15.4% among those ≤2 and 3-5 years of age, respectively). Frequency of RSV infection appeared to decrease with increasing age and was \<9% in those older than 5 years of age (*p* \< 0.0001). In contrast, influenza virus infection was more frequently found among older individuals. Meanwhile, hMPV infection was distributed among all ages (1.7--5.7%).
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###### Overall prevalence of samples tested positive for RSV, hMPV or influenza virus.
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  Year    No. of samples   Virus-positive samples (%)   RSV-positive (%)   hMPV-positive (%)   Influenza virus-positive (%)
  ------- ---------------- ---------------------------- ------------------ ------------------- ------------------------------
  2016    4,178            1,428 (34.2)                 590 (14.1)         114 (2.7)           814 (19.5)
  2017    4,664            1,271 (27.3)                 421 (9.0)          204 (4.4)           714 (15.3)
  Total   8,842            2,699 (30.5)                 1,011 (11.4)       318 (3.6)           1,528 (17.3)
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###### Characteristics of samples and detection frequency of RSV, hMPV, and influenza virus.
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  Characteristics             Samples (%) (*N* = 8,842)   RSV (%) (*N* = 1,011)   hMPV(%) (*N* = 318)   Influenza A+B (%) (*N* = 1,528)   
  --------------------------- --------------------------- ----------------------- --------------------- --------------------------------- --------------
  Age, year (mean ± SD age)   ≤2 (1.2 ± 0.6)              1,916 (21.7)            406 (21.2)            105 (5.5)                         134 (7.0)
                              3--5 (3.8 ± 0.8)            1,541 (17.4)            238 (15.4)            88 (5.7)                          160 (10.4)
                              6--12 (8.4 ± 1.9)           1,253 (14.2)            100 (8.0)             25 (2.0)                          298 (23.8)
                              13--18 (15.2 ± 3.2)         371 (4.2)               19 (5.1)              10 (2.7)                          101 (27.2)
                              19--30 (25.4 ± 3.2)         1,148 (13.0)            66 (5.7)              20 (1.7)                          211 (18.4)
                              31--60 (41.4 ± 8.1)         2,164 (24.5)            144 (6.7)             53 (2.4)                          516 (23.9)
                              \>60 (72.0 ± 9.1)           449 (5.1)               38 (8.5)              17 (3.8)                          108 (24.1)
  *p*-value                                                                       **0.0262**            0.5695                            **\<0.0001**
  Gender                      Male                        4,288 (48.5)            514 (50.8)            160 (50.3)                        742 (48.6)

**Notes.**

Statistically significant differences among groups are bolded.

Seasonal and genotype distribution of RSV, hMPV, and influenza virus
--------------------------------------------------------------------

The prevalence of viral etiology of influenza-like infection differed slightly among the viruses examined. Among 1,011 RSV-positive samples, subgroup identification was possible for 488 specimens. Of these, 36.3% (177/488) were RSV-A and 66.4% (324/488) were RSV-B. RSV infection appeared most frequently in the rainy months (between July and November) with the highest annual prevalence of 37% (206/555) and 17.3% (136/784) in August 2016 and September 2017, respectively ([Fig. 1A](#fig-1){ref-type="fig"}). Although RSV-A and RSV-B were equally detected in 2016, RSV-B was more frequently identified in 2017. From 318 hMPV-positive samples, subgroup identification was possible for 132 specimens. Of these, 80.3% (106/132) were hMPV-B, which was the predominant subgroup in both years ([Fig. 1B](#fig-1){ref-type="fig"}). From 1,528 samples tested positive for influenza virus, there were more influenza A virus (76.2%, 1,164/1,528) than influenza B virus (23.8%, 364/1,528). In 2016, high prevalence of influenza virus occurred twice, 20.5% (59/288) in March and 34.5% (234/678) in September ([Fig. 1C](#fig-1){ref-type="fig"}). The following year, peak influenza virus activity occurred in August (25.3%, 185/732). Overall, A/H3N2 accounted for 70% (815/1,164) of all influenza A virus.

![Seasonal distribution of infection for each virus.\
The monthly number of samples from patients with influenza-like illness (ILI) is shown in gray (right scale). (A) Bar graphs show RSV-positive rate with RSV-A in yellow and RSV-B in green (left scale). (B) Bar graphs show hMPV-positive rate with hMPV-A in blue and hMPV-B in red (left scale). (C) Bar graphs show frequency of influenza A (dark green) and influenza B (light green) virus infection with A/H1N1 in orange and A/H3N2 in pink (left scale).](peerj-07-6748-g001){#fig-1}

Genotyping and phylogenetic analysis of RSV and hMPV
----------------------------------------------------

Partial G gene sequences that were randomly selected to identify the RSV genotypes showed all of the RSV-A strains (23/23) were genotype ON1 and all of the RSV-B strains (93/93) were genotype BA9 ([Figs. 2A](#fig-2){ref-type="fig"} and [2B](#fig-2){ref-type="fig"}, respectively). Inter-subgroup diversity between A_ON1 and B_BA9 was relatively high (p-distance value of 2.17--2.44). In contrast, genetic variations among intra-genotype strains were relatively small (*p*-distance value of 0--0.073 and 0--0.071 within the ON1 and BA9 genotypes, respectively).

![Phylogenetic analysis of RSV subgroup A and B based on the nucleotide sequence encompassing the HVR2 region within the G gene.\
Trees were constructed using the maximum likelihood method based on the Tamura--Nei model and implemented in MEGA6. Bootstrap values of 1,000 pseudo-replications \>70% are indicated at the branch nodes. Reference sequences for each genotype (GA1--GA7, SAA1, NA1--NA4, and ON1 for RSV-A and GB1--GB4, SAB1--SAB4, URU1, URU2, THB, and BA1--BA10 for RSV-B) were obtained from GenBank. The scale bar represents the number of nucleotide substitutions per site between close relatives. Circles denote samples from Thailand 2016, while squares indicate strains from Thailand 2017 The number of strains are shown in parentheses.](peerj-07-6748-g002){#fig-2}

Partial F gene sequences were obtained from 132 of the 318 hMPV-positive specimens. Phylogenetic analysis of 132 hMPV strains identified in this study showed two main genetic lineages, A and B. Strains clustered into subgroup A2, B1, and B2, but not subgroup A1 ([Fig. 3](#fig-3){ref-type="fig"}). The majority of the strains belonged to subgroup B1 (74%, 98/132), while only 6% (8/132) belonged to subgroup B2. The remaining 20% of the strains (26/132) belonged to subgroup A2. The intra-genotype strains were genetically closely related (*p*-distance values of 0.001--0.019), while the inter-subgroup comparisons were more diverse (*p*-distance values of 0.087--0.116).

![Phylogenetic analysis of hMPV subgroup A and B based on the partial nucleotide sequence of the F gene.\
Tree was constructed using the maximum likelihood method and the Tamura--Nei model implemented in the MEGA6. The reliability of the tree was estimated using 1000 bootstrap pseudo-replicates. Bootstrap values \>70% are indicated at the branch nodes. Reference sequences for each genotype (A1, A2, B1, and B2) were obtained from GenBank. The scale bar represents the number of nucleotide substitutions per site between close relatives. Circles denote samples from Thailand 2016, while squares indicate strains from Thailand 2017. The number of strains are shown in parentheses.](peerj-07-6748-g003){#fig-3}

Coinfections among RSV, hMPV, and influenza virus
-------------------------------------------------

The frequency of single versus multiple infections and the number of co-occurrences of viruses for each possible virus combination were examined ([Table 4](#table-4){ref-type="table"}). The most common combination observed was RSV(non-typed) and influenza A H3N2 subtype (*n* = 68). As a percentage, the virus most often found in coinfections was RSV, which was found in 17.4% (176/1,011) of the samples, followed by hMPV (10.4%, 33/318), and influenza virus (8.5%, 130/1,528).

Discussion
==========

This study was conducted over a two-year study period between 2016--2017 among 8,842 patients who presented with influenza-like infections. Two multiplex real-time reverse transcriptase polymerase chain reaction (RT-PCR) assays were used to rapidly detect three of the most common viral respiratory pathogens. It was not surprising that influenza was the most prevalent virus (17.3%), followed by RSV (11.4%) and hMPV (3.6%). Similar to our findings, previous study examining hospitalized patients with lower respiratory tract infections in Thailand found that influenza viruses were the most common respiratory viruses diagnosed among ILI cases ([@ref-8]). RSV prevalence was highest among children aged \<5 years with rates of infection between 15.4 and 21.2%. On the other hand, RSV had a lower burden of symptomatic respiratory illness among older children and adults, and the opposite trend was observed for influenza virus infection. The proportion of patients with influenza virus infections increased with age, and the rate of infection was greatest in children 13--18 years of age (27.2%). These findings are supported by previously reported studies on the epidemiology of respiratory virus infection ([@ref-46]; [@ref-34]).
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###### Contribution of respiratory viruses as single or coinfections.
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  Virus                  Total     Single infections   Double infections   Triple infections   Mixed infection (%)   RSV (non-typed)   RSV-A   RSV-B   hMPV (non-typed)   hMPV-A2   hMPV-B1   hMPV-B2   Flu-H1N1   Flu-H3N2   Flu-B
  ---------------------- --------- ------------------- ------------------- ------------------- --------------------- ----------------- ------- ------- ------------------ --------- --------- --------- ---------- ---------- -------
  **RSV (non-typed)**    **527**   397                 128                 2                   **25.0**              --                0       0       18                 1         1         1         23         68         20
  **RSV-A**              **176**   158                 18                  0                   **10.2**              0                 --      13      1                  0         1         0         1          2          0
  **RSV-B**              **321**   293                 27                  1                   **8.7**               0                 13      --      3                  1         1         0         2          6          3
  **hMPV (non-typed)**   **186**   161                 22                  3                   **13.4**              18                1       3       --                 0         0         0         1          3          2
  **hMPV-A2**            **26**    24                  2                   0                   **7.7**               1                 0       1       0                  --        0         0         0          0          0
  **hMPV-B1**            **98**    93                  5                   0                   **5.1**               1                 1       1       0                  0         --        0         1          0          1
  **hMPV-B2**            **8**     7                   1                   0                   **12.5**              1                 0       0       0                  0         0         --        0          0          0
  **Flu-H1N1**           **349**   321                 28                  0                   **8.0**               23                1       2       1                  0         1         0         --         0          0
  **Flu-H3N2**           **815**   738                 75                  2                   **9.4**               68                2       6       3                  0         0         0         0          --         0
  **Flu-B**              **364**   338                 24                  1                   **6.9**               20                0       3       2                  0         1         0         0          0          --

In the present study, the seasonal distribution of influenza virus infections resembled those of RSV and hMPV infections, which was similar to data from previous studies ([@ref-34]; [@ref-32]; [@ref-8]). Although Thailand is located geographically in the northern hemisphere, the seasonality of respiratory infection is similar to that of several nearby tropical settings such as Indonesia, Malaysia, the Philippines and the Southern hemisphere countries of Australia and New Zealand ([@ref-43]; [@ref-33]). In these regions, respiratory infections generally peak in the rainy season and declines during the hot and dry months. Moreover, a study from Bangladesh found an increased risk of respiratory infection following rainy days, suggesting a link between rainfall and population crowding or proximity ([@ref-29]). In Thailand, the period when students are in school overlaps with the rainy season, so it is possible that host behavior is associated with an increased risk of respiratory infection.

In our study, both RSV subgroups A and B circulated during the same RSV season, but the relative proportions varied as subgroup B occurred more frequently than subgroup A in the 2017 season. Several previous studies including from our group have reported the alternating antigenic pattern of RSV infection over time ([@ref-30]; [@ref-18]; [@ref-13]; [@ref-3]; [@ref-39]). It has been hypothesized that the periodic shifts in the predominant RSV subgroup are driven by the dynamics of population immunity and subgroup-specific herd immunity ([@ref-7]). Regarding the relationship between clinical severity of infection and RSV types and subtypes, some studies have observed that RSV group A infection was associated with an increased illness severity ([@ref-27]; [@ref-21]), while other studies observed that RSV group B infection resulted in more severe disease ([@ref-19]; [@ref-40]). In the present study, the emerging genotypes of ON1 and BA9 completely replaced the previous genotypes, such NA1, and other BA genotypes as was found in other countries ([@ref-11]; [@ref-12]), although it has been observed that they do not appear to cause more severe disease than other genotypes ([@ref-31]).

Phylogenetic analysis of the hMPV F gene in the present study showed that both A and B types co-circulated in Thailand over the two-year study period. Similar to our findings, all three subtypes of hMPV (A2, B1, and B2) co-circulated each year in other studies, including South Korea, Italy, Australia, and Norway ([@ref-15]; [@ref-24]; [@ref-10]; [@ref-28]). Although hMPV genotype A might be more virulent than genotype B ([@ref-42]), data in the literature on the association between clinical symptoms and hMPV genotype remains unclear as some authors show a higher severity of illness, ([@ref-42]; [@ref-2]), while others did not ([@ref-1]; [@ref-26]). Furthermore, the prevalence of mostly influenza A H3N2 contrasts with the limited circulation of influenza B during this two-year study period. The predominance of influenza A H3N2 in 2016 was observed both in Thailand ([@ref-35]) and the United States ([@ref-4]).

Regarding multiple infections, RSV was co-detected mainly with influenza virus infection, which is consistent with an overlap of seasonal RSV and influenza virus infections. There have been reports showing no relationship between disease severity and multiple virus infections ([@ref-23]), while other studies have shown that viral co-infection was significantly associated with longer duration of symptoms, especially in RSV, and that this may increase the clinical severity of acute respiratory infection among children infected with RSV ([@ref-9]; [@ref-16]).

This study had several limitations. The convenient samples in this study may not be representative of the patient population in Bangkok. Since these samples were not tested for other respiratory viruses such as human parainfluenza virus and rhinovirus, we may have missed the identification of other respiratory pathogens. Samples were anonymized and had limited accompanying clinical data, therefore we were unable to examine the association between viral genotypes and clinical severity, although ILI clinical symptoms are generally similar regardless of viral etiology.

Conclusion
==========

Influenza viruses were the most common respiratory viruses diagnosed among ILI cases in this study. While RSV and hMPV infections were found mainly in young children and sporadically in adults, influenza virus infection was prevalent in adults and the elderly. A small number of individuals had dual infections, most commonly RSV and influenza A H3N2. Due to overlapping seasonal occurrence of these viral infections, accurate and rapid molecular detection can potentially assist clinicians and researchers in the treatment and surveillance to limit viral spread. The data presented here add to our understanding of the epidemiology of RSV, hMPV, and influenza causing respiratory illness in Thailand.

Supplemental Information
========================

10.7717/peerj.6748/supp-1

###### Reference strains of RSV used in the partial G gene phylogenetic tree

###### 

Click here for additional data file.

10.7717/peerj.6748/supp-2

###### Reference strains of hMPV used in the F gene phylogenetic tree

###### 

Click here for additional data file.

10.7717/peerj.6748/supp-3

###### The correlation of virus prevalence and age assessed using univariate analyses

###### 

Click here for additional data file.

10.7717/peerj.6748/supp-4

###### RSVA sequences

###### 

Click here for additional data file.

10.7717/peerj.6748/supp-5

###### RSVB sequences

###### 

Click here for additional data file.

10.7717/peerj.6748/supp-6

###### HMPV sequences

###### 

Click here for additional data file.

10.7717/peerj.6748/supp-7

###### RSVA sequence information for GenBank submission

###### 

Click here for additional data file.

10.7717/peerj.6748/supp-8

###### RSVB sequence information for GenBank submission

###### 

Click here for additional data file.

10.7717/peerj.6748/supp-9

###### hMPV sequence information for GenBank submission

###### 

Click here for additional data file.

10.7717/peerj.6748/supp-10

###### The number of monthly of samples for each virus

###### 

Click here for additional data file.

We would like to thank the staff of Bangpakok 9 International Hospital in Bangkok for their technical and administrative assistance.

Additional Information and Declarations
=======================================

The authors declare there are no competing interests.

[Ilada Thongpan](#author-1){ref-type="contrib"} conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.

[Nungruthai Suntronwong](#author-2){ref-type="contrib"} and [Preeyaporn Vichaiwattana](#author-3){ref-type="contrib"} performed the experiments, approved the final draft.

[Nasamon Wanlapakorn](#author-4){ref-type="contrib"} analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.

[Sompong Vongpunsawad](#author-5){ref-type="contrib"} analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.

[Yong Poovorawan](#author-6){ref-type="contrib"} conceived and designed the experiments, contributed reagents/materials/analysis tools, prepared figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

The Institutional Review Board of the Faculty of Medicine of Chulalongkorn University approved this study (IRB number 609/59).

The following information was supplied regarding data availability:

The raw data files are available in Supplemental Files and in GenBank: [MH447703](http://www.ncbi.nlm.nih.gov/nuccore/MH447703)--[MH447725](http://www.ncbi.nlm.nih.gov/nuccore/MH447725) (RSV-A), [MH447726](http://www.ncbi.nlm.nih.gov/nuccore/MH447726)--[MH447818](http://www.ncbi.nlm.nih.gov/nuccore/MH447818) (RSV-B), and [MH447819](http://www.ncbi.nlm.nih.gov/nuccore/MH447819)--[MH447950](http://www.ncbi.nlm.nih.gov/nuccore/MH447950) (hMPV).
